• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO MEDICAL CORPORATION 8F ANGIO-SEAL VIP VASCULAR CLOSURE DEVICE, OUS; DEVICE, HEMOSTASIS, VASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO MEDICAL CORPORATION 8F ANGIO-SEAL VIP VASCULAR CLOSURE DEVICE, OUS; DEVICE, HEMOSTASIS, VASCULAR Back to Search Results
Model Number N/A
Device Problems Difficult to Insert (1316); Material Deformation (2976)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/09/2024
Event Type  Injury  
Manufacturer Narrative
A review of the device history record of the product code/lot number combination was conducted with no findings.The actual device was not returned; therefore, an evaluation of the actual device was unable to be conducted.Since the sample was not available for evaluation, the complaint could not be confirmed.The exact root cause was unable to be determined.The likely cause was determined to be damage sustained to the sheath/locator assembly during device insertion.The device history record (dhr) review determined that the device was in a conforming state when released from terumo control.There is no indication that any manufacturing, design, or quality system issues may have led to this event.Currently, no action is recommended since this risk evaluation is within the predetermined limits in the failure mode and effects analysis (fmea)/hazard based risk table (hbrt).
 
Event Description
The user facility reported that when the involved angio-seal device was attempted to be used, the locator/insertion sheath assembly was not smoothly inserted into the artery from the puncture site, resulting in a kink in the assembly.The device was not used, and manual compression was applied to achieve hemostasis.Subsequently, hemostasis was successfully achieved with manual compression only.The estimated blood loss was less than 250cc's.The procedure before deploying the device was percutaneous coronary intervention (pci).A pre-deployment angiogram was performed.The size of the sheath ancillary used was 7 french.The puncture site was proximal to the inguinal ligament of the left common femoral artery.The vessel's diameter was 7 mm.The event occurred intra-operative.There is not a direct allegation that the reported device caused or contributed to patient injury and/or need for medical intervention.No equipment or other devices were used with the involved angio-seal device.
 
Manufacturer Narrative
This report is being submitted as follow up no.1 to provide a correction to the investigation summary in section h11.Since the sample was not available for evaluation, the complaint could not be confirmed.The exact root cause was unable to be determined.The likely cause was determined to have been off axis loading during device insertion.The device history record (dhr) review determined that the device was in a conforming state when released from terumo control.There is no indication that any manufacturing, design, or quality system issues may have led to this event.Currently, no action is recommended since this risk evaluation is within the predetermined limits in the failure mode and effects analysis (fmea)/hazard based risk table (hbrt).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
8F ANGIO-SEAL VIP VASCULAR CLOSURE DEVICE, OUS
Type of Device
DEVICE, HEMOSTASIS, VASCULAR
Manufacturer (Section D)
TERUMO MEDICAL CORPORATION
265 davidson ave
suite 320
somerset NJ 08873
Manufacturer (Section G)
TERUMO PUERTO RICO LLC
innovacion street lot 21
caguas west industrial park
caguas, 00725
Manufacturer Contact
gina digioia
265 davidson ave
suite 320
somerset, NJ 08873
4103927218
MDR Report Key18855930
MDR Text Key337103359
Report Number3013394970-2024-00092
Device Sequence Number1
Product Code MGB
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P930038
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/07/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/29/2024
Device Model NumberN/A
Device Catalogue Number610133
Device Lot Number0000367501
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/09/2024
Initial Date FDA Received03/07/2024
Supplement Dates Manufacturer Received03/12/2024
Supplement Dates FDA Received03/28/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured05/30/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-